Carboxylated Osteocalcin and Adiponectin Correlate with Glycated Hemoglobin and 25(OH) Vitamin D Levels in Saudi Females with Type 2 Diabetes Mellitus Following Ingestion of Vitamin D Supplements

References (62)

1. 1 Estimation of the Concentration of Low-Density Lipoprotein Cholesterol in Plasma, Without Use of the Preparative Ultracentrifuge [DOI]
2. 2 Global Prevalence of Diabetes [DOI]
3. 3 Mechanisms linking obesity to insulin resistance and type 2 diabetes [DOI]
4. 4 Endocrine Regulation of Energy Metabolism by the Skeleton [DOI]
5. 5 Glycemic Control With Diet, Sulfonylurea, Metformin, or Insulin in Patients With Type 2 Diabetes Mellitus Progressive Requirement for Multiple Therapies (UKPDS 49) [DOI]
6. 6 The Role of Vitamin D and Calcium in Type 2 Diabetes. A Systematic Review and Meta-Analysis [DOI]
7. 7 Hypovitaminosis D is associated with insulin resistance and β cell dysfunction [DOI]
8. 8 Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol [DOI]
9. 9 Serum 25-Hydroxyvitamin D, Diabetes, and Ethnicity in the Third National Health and Nutrition Examination Survey [DOI]
10. 10 Osteocalcin differentially regulates β cell and adipocyte gene expression and affects the development of metabolic diseases in wild-type mice [DOI]
11. 11 Vitamin D Insufficiency [DOI]
12. 12 Vitamin D Deficiency in Adults: When to Test and How to Treat [DOI]
13. 13 Vitamin D supplementation reduces insulin resistance in South Asian women living in New Zealand who are insulin resistant and vitamin D deficient – a randomised, placebo-controlled trial [DOI]
14. 14 Role of vitamin D in the pathogenesis of type 2 diabetes mellitus [DOI]
15. 15 THE EFFECT OF VITAMIN D3 ON INSULIN SECRETION AND PERIPHERAL INSULIN SENSITIVITY IN TYPE 2 DIABETIC PATIENTS [DOI]
16. 16 Intermittent injections of osteocalcin improve glucose metabolism and prevent type 2 diabetes in mice [DOI]
17. 17 Serum Osteocalcin Level Is Associated with Glucose Metabolism and Atherosclerosis Parameters in Type 2 Diabetes Mellitus [DOI]
18. 18 Association between Serum Osteocalcin and Markers of Metabolic Phenotype [DOI]
19. 19 Prevalence of Hypovitaminosis D in Cardiovascular Diseases (from the National Health and Nutrition Examination Survey 2001 to 2004) [DOI]
20. 20 Glucose intolerance and impairment of insulin secretion in relation to vitamin D deficiency in East London Asians [DOI]
21. 21 Serum 25-Hydroxyvitamin D Concentration and Subsequent Risk of Type 2 Diabetes [DOI]
22. 22 Vitamin D intake to attain a desired serum 25-hydroxyvitamin D concentration [DOI]
23. 23 Vitamin D3Improves Impaired Glucose Tolerance and Insulin Secretion in the Vitamin D-Deficient Ratin Vivo [DOI]
24. 24 The Relationship of Serum Osteocalcin Concentration to Insulin Secretion, Sensitivity, and Disposal with Hypocaloric Diet and Resistance Training [DOI]
25. 25 Vitamin K Status and Bone Health: An Analysis of Methods for Determination of Undercarboxylated Osteocalcin [DOI]
26. 26 Supplementation with cholecalciferol does not improve glycaemic control in diabetic subjects with normal serum 25-hydroxyvitamin D levels [DOI]
27. 27 Environmental Contaminants as Etiologic Factors for Diabetes [DOI]
28. 28 The uncarboxylated form of osteocalcin is associated with improved glucose tolerance and enhanced β‐cell function in middle‐aged male subjects [DOI]
29. 29 Reciprocal regulation of bone and energy metabolism [DOI]
30. 30 Vitamin D May Not Improve Lipid Levels [DOI]
31. 31 Epidemiology, Clinical and Complications Profile of Diabetes in Saudi Arabia: A Review [DOI]
32. 32 Glucose tolerance and vitamin D: Effects of treating vitamin D deficiency [DOI]
33. 33 Prevalence of vitamin D deficiency in Saudi adults [DOI]
34. 34 Circulating osteocalcin level is associated with improved glucose tolerance, insulin secretion and sensitivity independent of the plasma adiponectin level [DOI]
35. 35 Long-term vitamin D3 supplementation may have adverse effects on serum lipids during postmenopausal hormone replacement therapy [DOI]
36. 36 Preventing Non-Insulin-Dependent Diabetes [DOI]
37. 37 Changes in serum osteocalcin, plasma phylloquinone, and urinary gamma-carboxyglutamic acid in response to altered intakes of dietary phylloquinone in human subjects [DOI]
38. 38 Vitamin K supplementation reduces serum concentrations of under-γ-carboxylated osteocalcin in healthy young and elderly adults [DOI]
39. 39 A high phylloquinone intake is required to achieve maximal osteocalcin γ-carboxylation,, [DOI]
40. 40 Effect of 1 alpha (OH)-vitamin D3 on insulin secretion in diabetes mellitus.
41. 41 Effect of 5 y of calcium plus vitamin D supplementation on change in circulating lipids: results from the Women’s Health Initiative [DOI]
42. 42 Effects of a short-term calcium and vitamin D treatment on serum cytokines, bone markers, insulin and lipid concentrations in healthy post-menopausal women [DOI]
43. 43 Total and High Molecular Weight But Not Trimeric or Hexameric Forms of Adiponectin Correlate with Markers of the Metabolic Syndrome and Liver Injury in Thai Subjects [DOI]
44. 44 Vitamin D Status among Adult Saudi Females Visiting Primary Health Care Clinics [DOI]
45. 45 Vitamin D Deficiency Is More Common in Type 2 Than in Type 1 Diabetes [DOI]
46. 46 Effects of vitamin D supplementation on 25-hydroxyvitamin D, high-density lipoprotein cholesterol, and other cardiovascular disease risk markers in subjects with elevated waist circumference [DOI]
47. 47 Vitamin D supplementation does not affect serum lipids and lipoproteins in Pakistani immigrants [DOI]
48. 48 1,25(OH)2D3 inhibits the deleterious effects induced by high glucose on osteoblasts through undercarboxylated osteocalcin and insulin signaling [DOI]
49. 49 Vitamin D and pancreatic islet function I. Time course for changes in insulin secretion and content during vitamin D deprivation and repletion [DOI]
50. 50 Does vitamin D3 have negative effects on serum levels of lipids? A follow-up study with a sequential combination of estradiol valerate and cyproterone acetate and/or vitamin D3 [DOI]
51. 51 Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man [DOI]
52. 52 Baseline Serum 25-Hydroxy Vitamin D Is Predictive of Future Glycemic Status and Insulin Resistance [DOI]
53. 53 Vitamin D supplementation enhances the beneficial effects of weight loss on cardiovascular disease risk markers [DOI]
54. 54 Diabetes Mellitus in Saudi Arabia [DOI]
55. 55 Vitamin D across the lifecycle: physiology and biomarkers [DOI]
56. 56 γ-Carboxylation of osteocalcin and insulin resistance in older men and women [DOI]
57. 57 Effect of winter oral vitamin D3 supplementation on cardiovascular risk factors in elderly adults.
58. 58 Treatment with vitamin D or its analogues does not change body weight or blood glucose level in postmenopausal women.
59. 59 The role of calcium and magnesium in insulin secretion from rabbit pancreas studied in vitro [DOI]
60. 60 Lower vitamin D status is more common among Saudi adults with diabetes mellitus type 1 than in non-diabetics [DOI]
61. 61 Vitamin D metabolites regulate osteocalcin synthesis and proliferation of human bone cells in vitro [DOI]
62. 62 The future of insulin therapy for patients with type 2 diabetes mellitus.

Cited by 2

Related research

• Influence of Vitamin D Level on Diabetic Dyslipidemia — shares topic coverage
• Vitamin D and Insulin Resistance in Metabolic Syndrome — shares topic coverage
• Assessment of Vitamin D Knowledge and Awareness among Female Students of Applied Medical Sciences Faculty, Umm Al-Qura University — shares topic coverage
• Vitamin D: A Key Factor in Prostate Health — shares topic coverage
• Interrelationship between Non-Alcoholic Steatohepatitis and Vitamin D: A Mini Review — shares topic coverage